Vampt America, Inc.

CIK:0001365022|SEC Filings
v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Consolidated Statements Of Operations [Abstract]        
Revenue $ 65,982 $ 58,095 $ 131,491 $ 442,552
Cost of goods sold 96,940 185,454 179,770 543,214
Gross Profit (Loss) (30,958) (127,359) (48,279) (100,662)
Expenses        
Compensation and benefits 302,982 149,069 720,702 360,672
General and administrative 27,702 39,631 77,839 55,611
Product research and development    36,225    37,565
Professional fees 451,905 31,184 974,284 78,192
Sales and marketing 161,342 301,095 346,616 418,006
Travel 47,892 52,987 134,335 121,365
Operating expenses total 991,823 610,191 2,253,776 1,071,411
Other Income (Expense)        
Loss on extinguishment of debt       (457,777)   
Gain on derivative liability 938    2,061   
Interest expense (64,369) (6,226) (148,250) (6,226)
Net loss $ (1,086,212) $ (743,776) $ (2,906,021) $ (1,178,299)
Basic and diluted loss per common share $ (0.04)    $ (0.15)   
Weighted average number of common shares outstanding 24,221,680    18,883,090